CA2341431A1 - Monitor for estimating placenta and fetus well being - Google Patents

Monitor for estimating placenta and fetus well being Download PDF

Info

Publication number
CA2341431A1
CA2341431A1 CA002341431A CA2341431A CA2341431A1 CA 2341431 A1 CA2341431 A1 CA 2341431A1 CA 002341431 A CA002341431 A CA 002341431A CA 2341431 A CA2341431 A CA 2341431A CA 2341431 A1 CA2341431 A1 CA 2341431A1
Authority
CA
Canada
Prior art keywords
model
maternal
fetal
models
mathematical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002341431A
Other languages
French (fr)
Inventor
Yael Almog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tao Medical Technologies Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2341431A1 publication Critical patent/CA2341431A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16ZINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00Subject matter not provided for in other main groups of this subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/344Foetal cardiography

Abstract

System and screening method for determining characteristics of placenta and fetus in pregnant woman by using system identification techniques to determine whether a fetus is at immediate risk or should enter a high risk pregnancy follow-up. In particular, a system which is a combination of non invasive detectors for the acquisition of physiological signals, a procedure for synchronizing the acquired maternal and fetal signals, and algorithms developed for system identification of biological open-loop systems are employed. The maternal-fetal system has a purely causal relationship between input and output, connected by the placenta. Hence, the identification and modeling of the system reflect the interconnection relations.

Description

MONITOR FOR ESTIMATING PLACENTA AND FETUS WELL BEING
s FIELD AND BACKGROUND OF THE INVENTION
The present invention relates to a method and system for evaluating the condition of the placenta in pregnant women as well as the well being of the fetus and/or the mother by using physiological parameters and system identification methods. The invention is particularly applicable for 1o estimating the functionality and well being of the placenta and fetus from the second trimester on.
Medical Background It has become an increasing practice in obstetrics to evaluate the well being of the baby while it is still in utero. This practice called anterpartum 15 testing, has been extensively practiced since the early 1970 on certain high risk obstetrical patients. One of the uses of anterpartum testing is to determine how well the placenta is supplying the needed oxygen and nutrients to the growing fetus, and removing fetal wastes thefrom.
Almost 70 % of fetal deaths occurs before the onset of labor.
2o Antepartum fetal death accounts for nearly 40 % of all perinatal mortality in the United States. The majority of fetal deaths occur before 32 week's gestation.
Antepartum fetal deaths may, be divided into four broad categories: - w {i) chronic asphyxia of diverse origin; {ii) congenital malformations; (iii) 2s superimposed complications of pregnancy, such as Rhesus isoimmunization, placental abruption, hypertension, diabetes and fetal infection; and (iv) deaths of unexplained cause.
Based on available data, approximately 30 % of antepartum fetal deaths rnay be attributed to asphyxia, 30 % to maternal complications, 3o especially placenta abruption, hypertension, and preeclapmsia, 15 % to congenital malformations and chromosomal abnormalities, and 5 % to infection:
A large clinical experience has demonstrated that antepartum fetal assessment can have a significant impact on the frequency and cause of fetal deaths.
Indications for antepartum fetal monitoring in patients known to be s at risk of utero-placental insuff ciency include maternal, fetal, placental and background indications. Maternal indications- include prolonged pregnancy;
diabetes mellitus; hypertension and advanced maternal age. Fetal indications include: suspected IUGR (intrauterine growth restriction) and decreased fetal movements. Placental indications include: abruption of the to placenta and abnormal amniotic fluid. Background indications include:
previous stillbirth.
The fetus and the placenta depend upon unique physiological systems to provide an environment supporting fetal growth and development.
~s To appreciate the complexity of the placenta as a transfer organ, it is necessary to point out that the placenta provides the fetus with products that are essential fox its well being including essential nutrients, fluid and oxygen, and it serves as a route for clearance of fetal excretory products [ I
].
The transport characteristics of the placenta allow respiratory gases 2o and many solutes to reach equal concentration between the maternal intervillous space blood and fetal capillary blood. Thus, the rate of blood flow in~~these two circulations is important in the determination of fetal oxygen and nutrient supply. Over the course of a normal singleton gestation, uterine blood flow increases mare than SO-fold above non-25 pregnant values. Two factors contribute to this dramatic increase in blood flow: placental growth and maternal arterial vasodilatation.
The .uterine artery behaves as a nearly maximally dilated system.
Fetal blood flow to the umbilical circulation represents approximately 40 of the fetal cardiac output. During the 1 st trimester, increases in umbilical blood flow are proportional to fetal growth.

Many maternal organs undergo physiological changes during the course of pregnancy. Maternal cardiac output, the product of heart rate and stroke volume, increases about 30-50 % during pregnancy. The distribution of maternal cardiac output changes as pregnancy progresses. In the first trimester the uterus receives 3 % of the cardiac output, however it receives 17 % of the cardiac output near term. The percentage of cardiac output devoted to kidney, brain and skin is not dramatically altered by pregnancy.
Peripheral vascular resistance falls during pregnancy. The cause for this is the smooth muscle relaxing effect of high progesterone levels associated 1o with the pregnancy. There is a progressive rise in venous pressure in the lower extremities.
The placenta, the mother and the fetus make important contribution to the immunological maintenance of pregnancy.
Advances in perinatal and neonatal health care have resulted in a substantial reduction in perinatai mortality. These improvements primarily relate to better capabilities in treating maternal diseases during pregnancy, advance in neonatal care and may also be due to improvements in anteparium fetal surveillance techniques.
There are some medical conditions in pregnancy that may lead to 2o poor placental functioning such as diabetes, hypertension, anemia and prolonged pregnancy. In these conditions . it is of great importance to evaluate the placental functioning. For these or other indications - w obstetrician will determine whether one is in need to have anterpartum testing during the pregnancy.
Anteparium fetal testing is a term that embraces data from fetal movement counts to biophysical monitoring methods, such as contraction stress test, nonstress test, fetal biophysical monitoring prafile, amniotic fluid assessment, Doppler velocimetry, vibro-acoustic fetal stimulation and computerized fetal heart rate.
3o The following lists few of the tests used for fetal monitoring.

WO 00/I2002 PCTlUS99/18060 Antepartum~fetal heart rate testing (non stress test. NST): In NST, fetal heart rate acceleration in response to fetal movement are recorded via electronic equipment on a strip of paper.
CardiotocographvJ~CTG): CTG utilizes electronic equipment to s record the fetus' heart rate pattern. Uterine contractions, if present are also registered. This information is recorded on a strip of paper, producing a tracing that is read by the obstetrician. Certain changes in the fetal heart rate pattern can signal a problem.
Amniotic Fluid Index ~AFI): The amount of amniotic fluid to surrounding the fetus may be decreased in same high-risk pregnancies. The amount of amniotic fluid present is measured by ultrasound scanning.
Fetal Biophysical Profile ~FBP): The CTG trace is obtained and then four parameters are observed by ultrasound. The four parameters are fetal tone, fetal movements, fetal breathing, and the amniotic fluid index.
is Not all of these tests need to be performed at the same time.
Since there are many different pathophysiological processes leading to fetal asphyxia, indication-specific testing is reasonable and it may allow early identification of at-risk fetuses. The FBP is useful in the detection of developing fetal asphyxia even before it irreversible affects the fetus.
2o No program of anteparium fetal testing can completely remove the risk of fetal death. The most appropriate antepartum tests appear to be amniotic fluid volume assessment, fetal tone and fetal heart monitoring.
The use of Doppler ultrasound is not beneficial in most clinical cases. The single most effective test that distinguishes normal-small from 25 compromised small fetuses is the determination of the umbilical artery Doppler waveform.
Doppler velocimetry seems to be reliable in diagnosing conditions predisposing to IUGR such as chronic hypertension, collagen vascular disorders, and other diseases in which vasospasm plays a major role.
3o Hence, it remains uncertain which is the optimal Doppler ultrasound measurement of the uteroplacental circulation to obtain the best sensitivity and predictive values for evaluation of fetal and placental pathologies such as preeclampcia and IUGR [2].
The usual decrease in utheroplacental blood flow associated with uterine contraction, when superimposed with chronic utheroplacental s insufficiency (e.g., diabetes associated with vascular changes, postdatism) may result in acute fetal distress.
In contrast, maternal hypotension (e.g., after induction of spinal or epidural anesthesia) can cause acute fetal distress despite the presence of a normal utheroplacental unit. Furthermore, maternal positioning has a strong io influence on the condition of the fetus.
There are strong indications that the utheroplacental unit has specific characteristics which can be evaluated by a variety of external manipulations [3-13].
There is no doubt that better objective and advanced measures of ~ s placenta well being and fetal asphyxia and asphyxia-related morbidity are needed to allow far a more scientific approach of antenatal fetal surveillance.
Mathematical background A system is an object in which different kind of variables interact 2o and produce observable signals [14]. The observable signals that are of interest are usually referred to as "outputs". The system is also affected by external stimuli. External signals that can be manipulated by the observer - w are referred to as "inputs". Others are referred to as "disturbances" and can be divided into those that are directly measured and those that are only 2s observed through their influence on the output. The distinction between inputs and measured disturbances is often less important for the modeling process.
Clearly, the nation of a system is a broad concept and plays an important role in modern science. Dynamic systems are those for which the 3o current output value depends not only on the current external stimuli but also on earlier values.

When one interacts with a system, one needs to have a concept of how the system's variables relate to one another. With a broad definition, the' relationship among observed signals is referred to as "a model of the system". Models can come in various shapes with varying degree of s mathematical formalism. The intended use determines the degree of sophistication that is required to make the model purposeful.
Mathematical models describe the relationship among system variables in terms of mathematical expressions like difference or differential equations. Mathematical models may be characterized by a number of io adjectives (time continuous or time discrete, lumped or distributed, deterministic or stochastic, linear or nonlinear, etc.) signifying the type of differential equation used.
Basically, a model has to be constructed from observed data.
Mathematical models may be developed along two routs.
~s 4ne route is to split the system into subsystems, whose properties are . well understood from previous experience. These subsystems are then joined mathematically and a model of the whole system is obtained. This route is known as "Modeling", and does not necessarily involve any experimentation on the actual system.
2o The other route to mathematical as well as graphical models is directly based on experimentation. Input and output signals from the system, are recorded and subjected to data analysis in order to infer a model. This route is known as "System Identification", the final outcome of which is a model of the system under study.
25 System identification is the subject of constructing or selecting models of dynamic systems to serve certain purposes. A first step is to determine a class of models within which the search for the most suitable model is to be conducted. A model of a system is a description of its properties, suitable for a certain purpose. The model need not be a true and 3o accurate description of the system, nor need the user believe it to be so, in order to serve its purpose.

Quiet often it is not possible to determine, apriori, the coefficients characterizing the system from knowledge of the physical mechanisms that govern the system's behavior. Instead, the determination of all or some of them must be left to estimation procedures. The model thus becomes a set s of models and it is for the estimation procedure to select that member in the set that appears to be the most suitable for the purpose in question.
The procedure to determine a model of a dynamic system from observed input-output data involves four basic ingredients [14]:
1. The data: The input-output data which are recorded during a specific designed identification procedure.
2. A set of candidate models: A set of candidate models is obtained by specifying within which collection of models one is going to look for a suitable one.
3. A rule by which candidate models can be assessed using the is data: This is the identification method, and is based on the performance of the model when one attempts to reproduce the measured data. A deficient model in these respects makes one reject the model, while good performance will develop a certain confidence in the model.
20 4. The procedure of identification is repeated for nonoverlapping segments of each set of data, in order to evaluate the accuracy of the model and the confidence level of the results.
However, a model can never be regarded as a final and true description of the system. It can at best be regarded as a good enough 25 description of certain aspects of particular interest.
The present invention is based on the broad concept of system identification, using the relationship between mother and fetus as an input-output open-loop system connected by a connection function. System identification deals with the problem of building mathematical models of 3o dynamic systems, based on observed data. The area has matured into an established collection of basic techniques that are well understood and known to be successfully performed in practical applications [ 14~. Since the mother and fetus are connecting solely via the placenta, the present invention enables placental and fetal functionality assessment.
There is thus a widely recognized need for, and it would be highly s advantageous to have, a method and system for evaluating the condition of the placenta in pregnant women as well as the well being of the fetus by using physiological parameters and system identification methods.
SUMMARY OF THE INVENTION
to According to one aspect of the present invention there is provided a method of diagnosis of malfunction of a placenta and fetus in a pregnant woman having a maternal-placenta-fetal system.
According to further features in preferred embodiments of the invention described below, the method comprising the steps of (a) 1s simultaneously monitoring selected maternal and fetal physiological signals; (b) identifying a model describing the maternal-placenta-fetal system, and parameters describing the model; and (c) determining, according to the model and the parameters describing the model, the well being of the placenta.
2o According to another aspect of the present invention there is provided a method of diagnosis of pathologies of a fetus in a pregnant woman having a maternal-placenta-fetal system, the method comprising the steps of (a) simultaneously monitoring selected maternal and fetal physiological signals; (b) identifying a model describing the maternal-2s placenta-fetal system, and parameters describing the model; and (c) determining, according to the model and the parameters describing the , model, the well being of the fetus.
According to still another aspect of the present invention there is provided a method of diagnosis of a maternal-fetus relation in a pregnant 30 woman having a maternal-placenta-fetal system, the method comprising the steps of (a) simultaneously monitoring selected maternal and fetal physiological signals; (b) identifying a model describing the maternal-placenta-fetal system, and parameters describing the model; and (c) determining, according to the model and the parameters describing the model, the maternal-fetus relation.
Further according to the present invention there is provided a system for effecting the above methods, the system is thus for monitoring a pregnancy in a pregnant woman having a maternal-placenta-fetal system and comprising (a) at least one monitoring device for simultaneously monitoring selected maternal and fetal physiological signals; and (b) a ~o computerized system being in communication with each of the at least one monitoring devices fox identifying a model describing the maternal-placenta-fetal system, and parameters describing the model.
According to still further features in the described preferred embodiments while simultaneously monitoring the selected maternal and ~s fetal physiological signals the pregnant woman experiences a provoked external stimulus.
According to still further features in the described preferred embodiments the physiological signals are selected from the group consisting of ECG, BP, P02, PC02, blood flow, blood velocity, blood 2o volume, heart rate, systolic blood pressure, diastolic blood pressure, systolic/diastolic blood pressure ratio, resistance index, pulsatility index, thermal index and other Doppler flow indexes.
According to still further features in the described preferred embodiments the model is selected from the group consisting of wherein said model is selected from the group consisting of nonparametric models, parametric models, polynominal representation, simple autoregressive model, ARMAX model structure, output error structure, Box-Jenkins model structure, general parametric model structure, state space representation, linear time-varying models, time-invariant model, nonlinear models, nonlinear ARMAX, Wiener kernels model, Korenberg-Billings model and Volterra-Wiener model.

WD 00112002 PCT/US99/1$060 According to still further features in the described preferred embodiments the model is a best model describing the maternal-placenta-fetal system, the best model is selected out of a plurality of available models and according to predetermined criteria, including technical considerations, s such as, but not limited to, memomery comciderations, accuracy required, and considerations relating to computing power optimization.
Thus, the present invention is based on the broad concept of system identification, and more particularly on using the relationship between mother and fetus as an input-output open-loop system connected by a to connection function.
The present invention successfully addresses the shortcomings of the presently known configurations by providing a method and system for evaluating the condition of the placenta in pregnant women as well as the well being of the fetus by using physiological parameters and system t s identification methods.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention herein described, by way of example only, with reference to the accompanying drawings, wherein:
2o FIG. 1 is a schematic diagram of the maternal-placental-fetal circulation unit;
FIG. 2 is a block diagram of the basic concept in accordance with the teachings of the present invention;
FIG. 3 is a block diagram of an exemplary system for analyzing 2s signals of the maternal-fetal dynamic system according to the present invention;
FIG. 4 is a flow diagram of a preferred embodiment of a method of analyzing signals from maternal/fetus system in accordance with the present invention;
3o FIG. 5 describes the preprocessing steps;

FIG. 6 is a flow diagram of the mathematical procedure performed in the identif cation process;
FIG. 7 is an example of external manipulation, wherein a provocative test, hand grip, is performed far a period of 40 sec in a pregnant woman of s 26 weeks gestation age;
FIG. 8 is an example of model determination for steady state conditions; and FIG. 9 is the description of the statistical procedure following the identification procedure according to the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention is .of a method and system for evaluating a pregnant women which can be used for evaluating the condition of the placenta, as well as the well being of the fetus by using physiological ~s parameters and system identification methods. Specifically, the present invention can be used to detect pathologies associated with placental functioning long before a measurable pathology is detectable in the mother or fetus.
The principles and operation of a method and system according to 2o the present invention may be better understood with reference to the drawings and accompanying descriptions.
Before explaining at least one embodiment of the invention in detail, - w it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in 2s the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
3o According to a broad aspect of the present invention, there is provided a method of evaluating the placental-fetal-maternal conditions in pregnant women. The evaluation is performed according to the following steps.
First, selected maternal and fetal physiological signals are simultaneously monitored.
s Second, a model describing the maternal-placenta-fetal system and parameters describing the model are identified. The model and its parameters collectively define a connection function connecting the input (e.g., measured maternal physiological signals) and the output (e.g., simultaneously measured fetus physiological signals) or in other words to describing the maternal-placenta-fetal system.
Third, according to the model and the parameters describing the model, the placental-fetal-maternal conditions are evaluated, e.g., as normal or abnormal (e.g., pathological).
Preferably the input is chosen as the maternal signals and the output 1s as the fetus signals. However, the method can also be performed when changing the roles of the input-output, giving parameters which have no physiological meaning.
It will thus be appreciated that the present invention is based on the broad concept of system identification, using the relationship between the 2o mother and the fetus as an input-output open-loop system connected by a connection function.
As is strongly evident from the literature cited [3-13], there is a strong correlation between maternal and fetus parameters in various pathophysiological conditions. It is therefore clearly anticipated and it is 2s further shown hereinunder that the mother-placenta-fetus behave as a dynamic system.
System identification deals with the problem of building mathematical models of dynamic systems, based on observed data. The area has matured into an established collection of basic techniques that are 3o well understood and known to be successfully performed in practical applications [14]. The identification of models from data involves decision WO 00/12002 PCTlUS9911$060 l3 making while searching for a suitable model. One needs to go through several iterations along the process of arriving to a final model, where at each step previous decisions are revised. There are various techniques for system identification problems ranging from simple linear models to linear s models with noise and more complicated nonlinear models, some of which are described in greater detail hereinunder.
Referring now to the drawings, Figure 1 shows a schematic diagram of the maternal-placental-fetal circulation units. Maternal blood flows in the uterine blood circuit close to exchange surface 1, whereas fetal blood flows in the placental blood circuit close to exchange surface 1, such that maternal nutrients and oxygen present in the maternal blood cross the intervillous space 2 into the capillaries of the chorionic villi 3, whereas fetal waste products cross space 2 into the maternal blood.
Figure 2 is a basic block diagram of a dynamic system 10 according is to the present invention describing a maternal-placenta-fetus system.
System 10 features maternal input or inputs 1Z, a connection function 14 (i.e., model and model parameters), and fetus output or outputs 16.
Connection function 14 is selected to best connect between input or inputs 12 and output or outputs 16.
2o Figure 3 is a block diagram of an exemplary system 20 in accordance with the teachings of the present invention. The present invention may be used to~ evaluate a placenta 24, which is the connecting organ between the mother and the fetus, using signals derived from the maternal system 22, and the fetal system 26.
2s Maternal physiological parameters un, such as ECG, BP, P02, PC02, blood flow, blood velocity and blood volume or pseudo physiological signals, such as heart rate - HR, systolic blood pressure - S, diastolic blood pressure - D, resistance index - RI, pulsatility index - PI, or others, such as S to D ratio, ete., and fetal physiological parameters yn, such 3o as ECG, P02, PC02, blood flow, blood velocity and blood volume, or pseudo physiological signals, such as HR, S, D, RI, PI, S/D, etc., are simultaneously recorded using maternal 32 and fetus 30 suitable sensors or devices. If the pregnancy is of more than a single fetus {e.g., twins) separate monitoring may be performed for each of the fetuses by dedicated sensors.
s Recordings of the physiological parameters may be effected by sensors or devices known in the art, such as, but not limited to, ultra-sound imaging devices, MRI, electromagnetic sensors and sound wave sensors.
Others include those disclosed in, for example, U:S. Pat. Nos. 4,945,917;
5,596;993; 5;474,065; 5,442,940; 5,623,939; and 5,123,420, which are to incorporated by reference as if fully set forth herein.
As a first step following data acquisition, preprocessing of the data is performed. To this end, a computer system 28 is provided and via an analog to digital converter (AID) (when an analog signal is acquired) it creates discrete time series out of the various physiological parameter ~s recordings.
The various signals, from maternal origin and fetal origin are then synchronized and filtered in order to remove trends and experimental noise.
Physiological parameters of the fetus may also be detected using maternal sensors, for example the determination of fetal HR from maternal 2o ECG, see U.S. Pat. No. 4,945,917.
Computer system 28 then performs an iterative process to choose an optimal connection function 34. The characteristics of connection function 34, as well as the optimal connection function type are evaluated.
The maternal-placenta-fetal systems 22, 24, 26 are described with the 2s most adequate model parameters found. T'he results of the various estimations and characterizations of systems 22, 24, and 26 are then displayed using a display 36 or a printer 38.
The determined characteristics displayed or printed may be a number, numbers or a plot representative of the determined characteristics.
3o These displays, plots, or numbers may be used by the physician for diagnosis.

Shown in Figure 4, is a more detailed flow diagram describing the functionality of computer system 28. The first step 42, involves the acquisition of the physiological signals simultaneously taken from both the mother and the fetus. Then, at step 44, AID conversion is performed for 5 further computer analysis. Shown in step 46 (see also Figure 5) are the preprocessing steps to prepare the input and output data. In step 48, an iterative computation is executed, using system identification techniques, at the end of which an adequate description of the dynamic system is obtained.
In step 50 the outputs are evalated and optionally displayed. Further 1o description of this step is provided hereiunder with reference to Figure 9.
A detailed description of step 48 is presented in Figure 6. There are s various potential models to be used under step 52, a description of few is given hereinbelow:
L Linear time-invariant Sam Ides:tification is a. Nonparametric models For experimental data, the aim is to determine a set of functions by direct techniques without first selecting a confined set of possible models. Such methods are called nonparametric since they do not explicitly employ a finite-dimensional parameter vector in the search for the best description.
The nonparametric methods for describing linear models are composed of time-domain methods and frequency-domain methods of various degrees of sophistication.
Assuming that the input-output signals are related by a linear system, the relationship can be written:
1.
y(t) = G(q)u(t) + s(t) where:
u(t): t=1,2, .............N is the input.
y(t): t=1,2, .............N is the output.

q is the shift operator and 2.

G(q)u(t) _ ~g(k)u(t - k) k=l and s 3.
G(q) _ ~ g(k) q k ~ q ~ u(t) = u(t - ~) k=1 The numbers {g(k) } are called the impulse response of the system. g(k) is the output of the system at time k if the input is a single pulse at time zero.
The function G(q) is called the transfer function of the system.
When evaluated on the unit circle (q=etS°) gives the frequency function:
4.
G(e~W) ~s In Eq. 1 s(t} is an additional unmeasurable disturbance, noise.
Its properties can be expressed in terms of its auto spectrum:
5.
~~(~) _ ~R,.(z)a ~wz ~_-where R,,(z) is the covariance function of E(t). The disturbance s(t) 2o can also be described as filtered white noise:
6.
E(t)=H(c~e(t) where e(t) is white noise with variance ~, and 7.
zs ~v(~) _ ~~H(e'°')~Z
Eqs. 1 and 6 give a time domain description of the system, 8.
y(t) =G(q) u(t) +H(q)e(t) Eqs. 4 and 7 constitute a frequency domain description.
Both descriptions are called nonparametric model description s since they are not defined in terms of a finite number of parameters.
This basic description also applies to several input signals and several output signals.
b. Parametric models Parameter estimation methods for linear models are based on to the following procedure.
A set of candidate models must be selected, and parametrized as a model structure, using a vector 8. The search for the best model within the set then becomes a problem of determining or estimating a . There are many different Ways of organizing such a search and also ~s different views on what one should search for.
Given a description (Eq. 8) and having observed the input-output data u(t), y(t) the predictor error e(t) can be computed as:
9.
e(t)=H I (q)(y(t)-G(q)u(t)J
2o These errors are, for a given a and y, functions of G and H.
These in turn are parametrized by polynomial or by state space matrices.
(i) Polynomial representatioH
The functions G and H can be represented as a rational 2s function of q-j and specify the numerator and denominator coefficients in some way. Such model structure are also known as black-box models.
A commonly used parametric model is the ARX (simple autoregressive model) that corresponds to:

WO 00/12002 PCTIUS99lI8060 10.
G(q) = q nk B{q) ;
A(q) H(q) = A(q) where B and A are polynomials in the delay operator q-t 11.
A(q) =1 + a, q-' .........+ana q-na 12.
-nb+t B(q) = b, +bzq .........+bnbq The numbers ha and nb are the orders of the respective polynomial. The number nk is the number of delays from input to output. The model is usually written:
13.
A(q)y(t) = B(q)u(t -uk) + e(t) or y(t) + aG y(t -1}+.,...+a~ y(t - na) = bi u(t - nk) +bZ u(t - nk -1}+......+b~b u(t + nk - nb + 1) + e(t) Eq. 13 applies also to several input signals and several output signals, where A(q) and the coefficients a; become ny x ny matrix, B(q) and the coefficients bt, becomes ny x nu.
A more complex parametric model is called ARMAX rriodel structure:
14.
A(q)y(t) = B(q)u(t -nk) + C(q)e(t) -i c(q)=r+~,q +.....+~"~q where A(q) and B(q) are defined in Eqs. 11 and 12.
An Output Error (OE) structure is obtained as:
15.
y(t) = F~q~ a{t - nk) + e(t) with t9 -, -a Fty=t+ f~q +.....+ f~fq The so called Box-Jenkins (BJ) model structure is given by:
16.
Y(t) = p(9) a{t nk) + D(q) e(t) s with -I -nd D~lj)=1+(~1(~ +.....~1-dnd~
These models are special cases of the General parametric model structure:
17.
to A(q)Y(t) = F(9) utt nk) + D(q) e(t) with -, -n F(q)=I+ f ~q +.....+ f nIC~
and -f -rtd D(9)=1-h(~IC~' -~.....+~ndq ~5 Within the structure of Eq. 17, virtually all of the usual linear black box model structure is obtained. For example the ARX is obtained for nc=nd=nf--0, the ARMAX is obtained for nf--nd=D.
The structures discussed may give rise to 32 (25) different model sets, depending on which of the polynomials A, B, C, D and F ,.
2o are used. The same type of models can be defined for systems with an arbitrary number of inputs. They have the form:
18.
A(q)y(t) = B'(q) a (t _ nk )+.....+ B"u(q) a (t-nk ) + C(q) e(t) F (9) ' ' F~u (q) nu nn D(~) The most complete description is that of a multivariable 25 signals where the input (u) is an m-dimensional vector and the output (y) is a p-dimensional vector. The system is still given by:

WO 00112002 PCT/US99/1$060 19.
y(t)=G(q, 6)u(t)+H(q, 6)e(t) with G(q~ 6)=A-'(q)~B(q) s H(R'~ 6)=A-'(q) G(q,6) will be p x m matrix whose entries are rational functions of q-l.
(ii) State space representation In the state space the relationship between the input, noise, 10 and output signals is written as a system of f rst-order differential or difference equations using an auxiliary state vector x(t).
For the purpose of system identification it is especially useful in that insights into mechanisms of the system can usually be incorporated into state-space models than into other type of models.
1s The modeling usually leads to a representation:
20.
u(t + 1) = Ax(t) + Bu(t) 21.
Y(t) = Cx(t) + Du(t) + y(t) 2o Here the relationship between the input u(t) and the output y(t) is defined via the nx-dimensional state space vector x(t).
Il. Linear time-var~in$'System Identification While linear, time-invariant models form the most comman way for describing a dynamic system, it is also quiet often useful or 2s necessary to employ other descriptions such' as linear time-varying models.
A general linear system can then be described as:
22.
y(t)=~g' (k)u(t-k)+v(t) k=1 3o and if one writes 23.
g~(k) = g(t,t-k) one finds that 24.
y(t) _ ~g(t,s)u(s) + v(t) s=--ao where g(t,s),t = s,s+ 1,...., is the response at time t to a unit pulse at time s.
The function g(t,s) is also known as the "weighting function", since it describes the weight that the input at time s has on the output at time t. The description in Eq. 24 is quiet analogous to to the time-invariant model, except that the sequence gr(k) carries the time index t.
In general a time-varying transfer function can be introduced as:
25.
°° -k is Gf(q) _ ~gt(k)q x=
and then repeat the procedures introduced above.
It is important to note that other linear system identification iiiethods are available, such as time-varying state space model and linearization of nonlinear systems. The appropriate choice should be 2o evaluated as a part of the-identification procedure.
III. Nonlinear Svstem Identification A nonlinear relationship between input and output gives a rich variety of possibilities to describe the system. At the same time, the situation is far too flexible to allow for definite deduction from finite 25 data records.
Even a first-order model without disturbances is specified only up to members in a general infinite-dimensional function space, while the corresponding linear model is characterized in terms of two real numbers.
In most cases, in order to use nonlinear models, some knowledge about the systems nonlinearities is needed in order to be s able to create reasonable model structure.
The development of models for nonlinear systems is quite analogous to that described for linear systems. The basic difference is that the predictor function - which is enabling the prediction of future values - becomes a nonlinear function of past observations.
to The important difference from a practical point of view is that the potential richness of possibilities makes unstructured "black-box"
models unfeasible in most cases. Instead, knowledge about the character of nonlinearities will have to be built into the models.
Such structure does not have to be analytical, the nonlinearities can is be defned in look-up tables, and the models parameters could be entries in these tables.
There are many methods to examine nonlinear systems, methods such as NARMAX (nonlinear ARMAX) which is an extension of the commonly used parametric linear methods, up to 20 very sophisticated nanlinear models such as Wiener results (kernels) [15] and Korenberg-Billings model [16].
The Volterra-Wiener approach is using the estimation of system kernels from input-output data. This technique employs Laguerre expansions of the kernels and estimates the unknown 2s expansion coefficient via time-averaging of covariance samples [17].
The Wiener kernels can also be estimated using cross correlations [18] and stochastic methods [19].
Referring again to Figure 6, in step 54, after deciding about the model structure, the basic model is selected out of a set of models according 3o to a predetermined fit criterion. Assuming, for example, that the linear models family is selected, the best model in the family of linear models is picked up.
In step 56 the estimate that results from the model is evaluated. If the estimate is a good estimate according to a predetermined criterion, step s 58, the identification of the connection function, is complete, whereas if not, step 54 reexecuted and a different family of models is searched for a best model describing the dynamic system.
Figures 7a-c present the results of a maternal external stimulus provoked by hand grip. During hand grip, there is an increase in maternal io HR (Figure 7a), a decrease in maternal peripheral flow (PPG, Figure 7b), and, resulting from the exercise, there is a change in fetal HR (Figure 7c).
Following the exercise there is a fast recovery of maternal HR and flow and a slow recovery of fetal HR. This example shows that external maternal manipulation results in fetal immediate reactivity.
15 Figures 8a-c presents the result of an identification procedure on the following physiological signals: maternal HR (Figure 8a), maternal peripheral flow (Figure 8b) obtained by the PPG device - which is a measure of red blood cells concentration, and fetal HR (Figure 8c). The experiment was performed on a healthy 29 years old multipara having a 2o normal pregnancy of 26 weeks gestation.
A linear model was chosen and it was found that the best model is the Box Jenkins (BJ) model, which is a special case of the general w parametric model structure shown in Figure 8d. As shown in Figure $e, the best model was achieved with the following degrees of freedom and 2s parameters: na = 2; nb = 2; nc = 2; nd = 2; nk = 1.
Figure 8f shows the quality of this model. One way to find out the quality of a model is to simulate it and compare the model output with measured output. To this end, one selects a portion of the original data that was not used to build the model: The accuracy (or predictivity) of the 3o model in this case was 67.8 %.

When dealing with fetal HR the dynamics of the HR results from two sources: internal origin (autonomic nervous system) and external origin.
The model in this case should explain the external contribution to fetal HR.
Therefore, a 67.8 % can be considered a very good fit.
s Figure 9 describes the statistical part of the system, step 60. In step 62 one adds to the information the week of gestation. In step 64 the results of the system identification are evaluated, taking into account the week of gestation, the family model which was used, the specific model within the model structure, the parameters of that specific model and the accuracy of to the model. The conditions of the maternal-fetal unit are statistically evaluated for discriminating between high risk or low risk according to a data base previously accumulated. If further interpretation of the test such as the type of the pathology or the level of risk is available it can also be presented.
This present invention is based on the fact that the maternal-placenta-fetal dynamic system is described by open-loop models, as there is no feedback loop between the fetus and the mother.
System identif cation techniques, where physiological signals obtained from a specific individual in order to create a model for maternal 2o placenta-fetal regulation, are applied to the recorded data. The search for the appropriate model should preferably start from simple linear models and advance to more complex nonlinear models in case the linear models fail to - w describe the system to the extent the clinical demands require, that is that the prediction function does not permit an accurate prediction according to 2s the rules established in the beginning of the identif cation procedure.
As such, system identification is a desirable tool for evaluating the effect of physiological alterations resulting from different pathologies, a change in environmental conditions and physiological stress, such as exercise.
3o It should be noted that a correlation between maternal pathological conditions are strongly correlated with fetus pathologies.

WO 00112002 PCT/US9911$060 Pregnancies complicated by chronic hypertension are at increased risk for the development of superimposed preeclampsia, abruptio placentae, and poor perinatal outcome. As for the severity of hypertension in the first trimester, the reported incidence of superimposed preeclampsia ranges from s 28.2 % to 52 % in severe chronic hypertension. On the other hand, the reported incidence for patients with mild hypertension in pregnancy is as low as 4.7 % less.
The incidence of abruptio placenta is reportedly increased and ranges between 0.45 % and 10 % depending an the duration of hypertension [20].
io The main risks to the fetus of the eclamptic woman are abruptio placentae, prematuity, intrauterine growth retardation.
Systemic lupus erythematosus (SLE), is a chronic disease with great diversity of clinical manifestations. SLE is associated with an increase in poor pregnancy outcome (from IUGR, stillbirth, spontaneous abortion and 15 preterm delivery). The SLE antibodies axe found in SO % of patients with SLE, and are associated with increases risk of pregnancy loss [21].
During pregnancy in the insulin-dependent diabetic woman, periods of maternal hyperglycemia lead to fetal hyperinsulinemia and thus fetal pancreatic stimulation. The resulting fetal hyperinsulinemia is associated 2o with excessive fetal growth and other morbidities. Congenital malformations are two times mare common in the offspring of insulin-dependent diabetic woman. Reduced uterine blood flow is thought to contribute to the increased incidence of intrauterine growth restriction (IUGR) observed in pregnancies complicated by diabetic vasculopathy [22].
2s Placenta blood flow is very sensitive to changes in maternal hemodynamic status. Administering anesthesia, either regional or general, to a parturient must involve efforts to avoid fetal compromise secondary to hypotension or intense uterine vasoconstriction. The supine position is avoided at all times, especially during anesthesia. Maternal compensation 3o for the efforts of vena caval compression that normally occur in the absence of anesthesia can be significantly impaired when anesthesia depresses vascular reflex mechanisms. Laboring patients with epidural analgesia requiring nursing in a full or semilateral position at all times. General anesthesia is induced with the patient in a 15-degree left lateral tilt.
Additionally, sudden alterations of blood pressure are avoided. Failure to s treat hypotension will rapidly produce changes in the fetal heart rate tracing suggestive of hypoxia [23].
Thus, it is evident that maternal pathological conditions are strongly correlated with fetus pathologies, whereas the reason for that is the dynamic open loop system characterizing the maternal-placenta-fetus.
io Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art.
Accordingly, it is intended to embrace all such alternatives, modif cations 1s and variations that fall within the spirit and broad scope of the appended claims.
LIST OF REFERENCES CITED
1. Williams Obstetrics, Pritchard and Mc Donald eds., Appleton-Century-Crofts, New York, 1980.
2. Northe R.A., Ferrier C, Long D, Townend K and ,Pinkus-Smith P. Uterine artery and flow velocity waveforfns in the second trimester for the prediction of preeclampcia and fetal growtlz retardation. Obstetrics and Gynecology Vol 83 pp.
378-386, 1994.
3. Gusdon JP Jr, Anderson SG, May WJ. A clinical evaluation of the "roll-over test" for pregnancy induced hypertension.
Am J obstet Gynecol 1: 127(1): 1-3, Jan 1997.
4. Eneroth-Grimforms E, Bevegard S, Nilsson Ba. Evaluation of three simple physiological tests as predictors of pregnancy-induced hypertension. A pilot study. Acta Obstet Gynecol Scand; 67(2):109-I13, 1988. .
5. Peck TM A simple test for predicting pregnancy-induced hypertension. Obstet Gynecol 50{5):615-617 Nov 1977.
6. Andersen GJ. The roll over test as a screening procedure for gestational hypertension. Aust N Z J Obstet Gynecol 20{3):
144-150, Aug 1980.
7. Baker PN, Johnson IR. The use of the hand-grip test far predicting pregnancy - induced hypertension. Eur J Obstet Gynecol Reprod Biol 56(3):169-172, Sep 1994.
8. Degani S, Abinader E, Eibschitz I, Oettinger M, Shapiro I, Sharf M. Isometric exercise test for predicting gestational hypertension. Obstet Gynecol 65(5):652-654, May 1985.
9. Loyke HF. Cold pressor test as a predictor of the severity of hypertension. Sounth Med J ; 88(3):300-304, May 1995.
I0. Chang C, Zhang J. T'he analysis of relationship between fetal stress and blood dynamics in fetal vessels and placenta bed vessels. Chung Hau Fu Vhan Tsa Chin 31(1)46:15-17, Jan.
1996.
11. Cottrill CM, Jeffers Lo J, Ousey JC, McGladdery AJ, Ricketts SW, Silver M, Rossdale PD. The placenta as a determinant of fetal well being in normal and abnormal pregnancies. J.
Reproduct Fertil Suppl 44:591-601, 1991.
12. Fairlie FM. Doppler flow velocimetry in hypertension in pregnancy. Clin Perinatol 1$(4):749-778, Dec 1991.
13. Badalian SS. Nature and mechanism of hemodynamic changes in fetuses of mothers with various types of diabetes mellitus. Akush Ginekol Mosk 9:39-42, Sep 1989.
14. Ljung L. System Identiftcation; theory for the user. Prentice-Hall Inc., Englwood Cliffs, New Jersy. Edited by T. Kailath, 1987.
15. Wiener N: Nonlinear problems in random theory. New York Wiley; 1958.
16. Sun H.H and Shi J.H. New algorithm for Korenberg-Billings model of nonlinear system identification. In: Advanced method of physiological system modeling: VoI II. New-Yoxk:
Plenum Publishing; 1989: pp. 179-200.
17. Marmaralis VZ: Identif catian of nonlinear biological systems using Laguerre expansion of kernels. Ann Biomed Eng, F
21:573-589, 1993.
18. Schetzen M, Lee YW: Measurements of the Wiener kernels of nonlinear system by cross correlation: Int J control, 2: 237-254, 1965.
19. Goussard Y. Wiener kernel estimation: A comparison of cross correlation and stochastic approximation methods. In:
advanced methods of physiological system modeling: Vol I.
Los Angeles, California:USC Biomedical Simulations Resources; 1987: pp: 289-302.

20. Sibal BM, Abdella TN, Anderson GD. Pregnancy outcome itt 211 patients with mild chronic hypertension. Obstet &
Gynecol 78:451, 1991.
2I. Branch DW, Scott JR et al. Obstetrics complications associated with the lupus anticoagulant. N Eng J Med 313:1322, 1985.
22. Nyland L et al. Uteroplacental blood ,fl'ow in diabetic pregnancy. Am J Obstet Gynecol 144:298, 1982.
23. Corke CB. Complications of obstetric anesthesia. In Francis MJ (ed} Obstetric anesthesia: The complicated patient. F. A.
Davis, 1990.
These documents are incorporated by reference as if fully set faith herein.

Claims (19)

WHAT IS CLAIMED IS:
1. A method of determining the well being of a placenta in a pregnant woman having a maternal-placenta-fetal system, the method comprising the steps of (a) simultaneously monitoring selected maternal and fetal physiological signals;
(b) using said physiological signals for identifying a mathematical model describing the maternal-placenta-fetal system, and mathematical parameters describing said model; and (c) determining, according to said mathematical model and said mathematical parameters describing said mathematical model, the well being of the placenta.
2. The method of claim 1, wherein while simultaneously monitoring said selected maternal and fetal physiological signals the pregnant woman is provoked by an external stimulus.
3. The method of claim 1, wherein said physiological signals are selected from the group consisting of ECG, BP, PO2, PCO2, blood flow, blood velocity, blood volume, heart rate, systolic blood pressure, diastolic blood pressure, systolic/diastolic blood pressure ratio, resistance index, pulsatility index, thermal index.
4. The method of claim 1, wherein said mathematical model is selected from the group consisting of nonparametric models, parametric models, polynominal representation, simple autoregressive model, ARMAX
model structure, output error structure, Box-Jenkins model structure, general parametric model structure, state space representation, linear time-varying models, time-invariant model, nonlinear models, nonlinear ARMAX, Wiener kernels model, Korenberg-Billings model and Volterra-Wiener model.
5. The method of claim 1, wherein said step of identifying said mathematical model is effected by identifying a best mathematical model describing the maternal-placenta-fetal system, said best mathematical model is selected out of a plurality of available mathematical models and according to predetermined criteria.
6. A method of determining the well being of a fetus in a pregnant woman having a maternal-placenta-fetal system, the method comprising the steps of (a) simultaneously monitoring selected maternal and fetal physiological signals;
(b) using said physiological signals for identifying a mathematical model describing the maternal-placenta-fetal system, and mathematical parameters describing said mathematical model;
and (c) determining, according to said mathematical model and said mathematical parameters describing said mathematical model, the well being of the fetus.
7. The method of claim 6, wherein while simultaneously monitoring said selected maternal and fetal physiological signals the pregnant woman is provoked by an external stimulus.
8. The method of claim 6, wherein said physiological signals are selected from the group consisting of ECG, BP, PO2, PCO2, blood flow, blood velocity, blood volume, heart rate, systolic blood pressure, diastolic blood pressure, systolic/diastolic blood pressure ratio, resistance index, pulsatility index, thermal index.
9. The method of claim 6, wherein said mathematical model is selected from the group consisting of nonparametric models, parametric models, polynominal representation, simple autoregressive model, ARMAX
model structure, output error structure, Box-Jenkins model structure, general parametric model structure, state space representation, linear time-varying models, time-invariant model, nonlinear models, nonlinear ARMAX, Wiener kernels model, Korenberg-Billings model and Volterra-Wiener model.
10. The method of claim 6, wherein said step of identifying said mathematical model is effected by identifying a best mathematical model describing the maternal-placenta-fetal system, said best mathematical model is selected out of a plurality of available mathematical models and according to predetermined criteria.
11. A method of determining a maternal-fetus relation in a pregnant woman having a maternal-placenta-fetal system, the method comprising the steps of:
(a) simultaneously monitoring selected maternal and fetal physiological signals;
(b) using said physiological signals for identifying a mathematical model describing the maternal-placenta-fetal system, and mathematical parameters describing said mathematical model;
and (c) determining, according to said mathematical model and said mathematical parameters describing said mathematical model, the maternal-fetus relation.
12. The method of claim 11, wherein while simultaneously monitoring said selected maternal and fetal physiological signals the pregnant woman is provoked by an external stimulus.
13. The method of claim 11, wherein said physiological signals are selected from the group consisting of ECG, BP, PO2, PCO2, blood flow, blood velocity, blood volume, heart rate, systolic blood pressure, diastolic blood pressure, systolic/diastolic blood pressure ratio, resistance index, pulsatility index, thermal index.
14. The method of claim 11, wherein said mathematical model is selected from the group consisting of nonparametric models, parametric models, polynominal representation, simple autoregressive model, ARMAX
model structure, output error structure, Box-Jenkins model structure, general parametric model structure, state space representation, linear time-varying models, time-invariant model, nonlinear models, nonlinear ARMAX, Wiener kernels model, Korenberg-Billings model and Volterra-Wiener model.
15. The method of claim 11, wherein said step of identifying said mathematical model is effected by identifying a best mathematical model describing the maternal-placenta-fetal system, said best mathematical model is selected out of a plurality of available mathematical models and according to predetermined criteria.
16. A system for monitoring of a pregnancy in a pregnant woman having a maternal-placenta-fetal system, the system comprising:
(a) at least one monitoring device for simultaneously monitoring selected maternal and fetal physiological signals; and (b) a computerized system being in communication with each of said at least one monitoring devices for identifying a mathematical model describing the maternal-placenta-fetal system, and mathematical parameters describing said mathematical model:
17. The system of claim 16, wherein said physiological signals are selected from the group consisting of ECG, BP, PO2, PCO2, blood flow, blood velocity, blood volume, heart rate, systolic blood pressure, diastolic blood pressure, systolic/diastolic blood pressure ratio, resistance index, pulsatility index, thermal index.
18. The system of claim 16, wherein said mathematical model is selected from the group consisting of nonparametric models, parametric models, polynominal representation, simple autoregressive model, ARMAX
model structure, output error structure, Box-Jenkins model structure, general parametric model structure, state space representation; linear time-varying models, time-invariant model, nonlinear models, nonlinear ARMAX, Wiener kernels model, Korenberg-Billings model and Volterra-Wiener model.
19. The system of claim 16, wherein said mathematical model is a best mathematical model describing the maternal-placenta-fetal system, said best mathematical model is selected out of a plurality of available mathematical models and according to predetermined criteria.
CA002341431A 1998-08-27 1999-08-09 Monitor for estimating placenta and fetus well being Abandoned CA2341431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/140,889 US6024701A (en) 1998-08-27 1998-08-27 Method of and system for estimating placenta and fetus well being using system identification techniques
US09/140,889 1998-08-27
PCT/US1999/018060 WO2000012002A1 (en) 1998-08-27 1999-08-09 Monitor for estimating placenta and fetus well being

Publications (1)

Publication Number Publication Date
CA2341431A1 true CA2341431A1 (en) 2000-03-09

Family

ID=22493253

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002341431A Abandoned CA2341431A1 (en) 1998-08-27 1999-08-09 Monitor for estimating placenta and fetus well being

Country Status (7)

Country Link
US (1) US6024701A (en)
EP (1) EP1107689A1 (en)
JP (1) JP2002523168A (en)
AU (1) AU5345799A (en)
CA (1) CA2341431A1 (en)
IL (1) IL141594A0 (en)
WO (1) WO2000012002A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610012B2 (en) * 2000-04-10 2003-08-26 Healthetech, Inc. System and method for remote pregnancy monitoring
US20030018457A1 (en) * 2001-03-13 2003-01-23 Lett Gregory Scott Biological modeling utilizing image data
US7016715B2 (en) * 2003-01-13 2006-03-21 Nellcorpuritan Bennett Incorporated Selection of preset filter parameters based on signal quality
US20040254430A1 (en) * 2003-06-13 2004-12-16 Hamilton Emily F. Method and apparatus for monitoring an obstetrics patient
US7374539B2 (en) * 2003-09-02 2008-05-20 University Of Utah Research Foundation Method and apparatus for predicting material hypertension during pregnancy using coherence analysis of material and fetal blood velocity waveforms
US7245558B2 (en) * 2004-06-18 2007-07-17 Symbol Technologies, Inc. System and method for detection using ultrasonic waves
US7996075B2 (en) * 2004-10-20 2011-08-09 Cardionet, Inc. Monitoring physiological activity using partial state space reconstruction
US7729753B2 (en) * 2006-03-14 2010-06-01 Cardionet, Inc. Automated analysis of a cardiac signal based on dynamical characteristics of the cardiac signal
US10092195B2 (en) 2006-08-17 2018-10-09 Jan Medical, Inc. Noninvasive detection of human brain conditions and anomalies
US10076274B2 (en) 2006-08-17 2018-09-18 Jan Medical, Inc. System and method for non-invasive detection of human cranial conditions
CA2681926A1 (en) * 2007-03-28 2008-10-02 The London Health Sciences Centre Research Inc. Eeg monitor of fetal health
CA2583524A1 (en) 2007-03-28 2008-09-28 Robert J. Cases Universal holder system
JP4960162B2 (en) * 2007-07-17 2012-06-27 株式会社東芝 Ultrasonic diagnostic equipment
JP5289004B2 (en) * 2008-11-18 2013-09-11 株式会社東芝 Ultrasonic diagnostic equipment
US9131860B2 (en) * 2008-12-29 2015-09-15 Mark Evans Identifying the level of fetal risk during labor
US8200319B2 (en) * 2009-02-10 2012-06-12 Cardionet, Inc. Locating fiducial points in a physiological signal
GB2471667B (en) * 2009-07-06 2011-11-09 Monica Healthcare Ltd Monitoring uterine activity
TWI392480B (en) * 2009-10-21 2013-04-11 Ind Tech Res Inst Apparatus and method for maternal-fetal surveillance
CN102499643B (en) * 2011-10-31 2014-02-12 深圳市理邦精密仪器股份有限公司 Mother's life sign and fetus united monitoring method and system thereof
DK2785251T3 (en) 2011-12-01 2021-06-07 Centaflow As Multifactorial pregnancy and birth monitoring with telesealth
WO2013175314A2 (en) * 2012-05-23 2013-11-28 Convergent Engineering, Inc. System and method for detecting preeclampsia
WO2015153409A2 (en) * 2014-04-01 2015-10-08 Montclair State University System and method for predicting fetal and maternal health risks
US10307065B1 (en) 2014-12-09 2019-06-04 Jan Medical, Inc. Non-invasive detection of cerebral vasospasm
EP3229669A4 (en) * 2014-12-09 2018-06-13 Jan Medical, Inc. Noninvasive detection of human brain conditions and anomalies
KR101887120B1 (en) * 2016-02-19 2018-08-09 계명대학교 산학협력단 Measurement and management system for fetal movement and belly aggregation of pregnant women, and the method thereof
IL266707B2 (en) 2016-11-21 2023-03-01 Evans Mark System, apparatus, and method for monitoring and assessing the level of fetal risk during labor
CN108209935B (en) * 2016-12-09 2023-04-07 西安理邦科学仪器有限公司 Fetal monitoring method and system for checking blood gas data
WO2024023398A1 (en) * 2022-07-23 2024-02-01 Universite Paris Cite System and method for determining the risk of fetal hypoxia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4821732A (en) * 1987-04-23 1989-04-18 Jack Lippes Method for monitoring fetal-material circulation time
US5123420A (en) * 1991-03-25 1992-06-23 Hewlett-Packard Company Method and apparatus for processing heart rate traces in a fetal monitor
EP0564459B1 (en) * 1991-10-24 1996-05-15 Hewlett-Packard GmbH Apparatus and method for evaluating the fetal condition
US5425362A (en) * 1993-07-30 1995-06-20 Criticare Fetal sensor device
US5433204A (en) * 1993-11-16 1995-07-18 Camilla Olson Method of assessing placentation
US5474065A (en) * 1994-04-04 1995-12-12 Graphic Controls Corporation Non-invasive fetal probe
US5623939A (en) * 1994-05-19 1997-04-29 Board Of Regents, University Of Texas System Method and apparatus for analyzing uterine electrical activity from surface measurements for obstetrical diagnosis
US5596993A (en) * 1994-09-21 1997-01-28 Beth Israel Hospital Fetal data processing system and method

Also Published As

Publication number Publication date
EP1107689A1 (en) 2001-06-20
WO2000012002A1 (en) 2000-03-09
IL141594A0 (en) 2002-03-10
AU5345799A (en) 2000-03-21
US6024701A (en) 2000-02-15
JP2002523168A (en) 2002-07-30

Similar Documents

Publication Publication Date Title
US6024701A (en) Method of and system for estimating placenta and fetus well being using system identification techniques
US6340346B1 (en) Method and system for system identification of physiological systems
Heinonen et al. Perinatal diagnostic evaluation of velamentous umbilical cord insertion: clinical, Doppler, and ultrasonic findings
Bower et al. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre‐eclampsia and intrauterine growth retardation
Frank et al. Permutation entropy improves fetal behavioural state classification based on heart rate analysis from biomagnetic recordings in near term fetuses
Huhn et al. New computerized fetal heart rate analysis for surveillance of intrauterine growth restriction
US5957855A (en) Fetal data processing system and method employing a time-frequency representation of fetal heart rate
DE69926259T2 (en) DIAGNOSTIC TOOL USING A PREDICTIVE INSTRUMENT
Grimm et al. Recommended standards for fetal magnetocardiography
Rivolta et al. Theoretical value of deceleration capacity points to deceleration reserve of fetal heart rate
Malcus Antenatal fetal surveillance
Castro et al. Systematic review of intrapartum fetal heart rate spectral analysis and an application in the detection of fetal acidemia
Illanes et al. Fetal heart rate feature extraction from cardiotocographic recordings through autoregressive model's power spectral-and pole-based analysis
Pattinson et al. Umbilical artery resistance index as a screening test for fetal well-being. I: Prospective revealed evaluation
Burrus et al. The predictive value of intrapartum fetal heart rate abnormalities in the extremely premature infant
Tagliaferri et al. Impact of nuchal cord on antenatal and intrapartum foetal heart rate surveillance and perinatal outcome
Tagliaferri et al. Ethnic analogies and differences in fetal heart rate variability signal: A retrospective study
Euliano et al. Photoplethysmography and heart rate variability for the diagnosis of preeclampsia
Vairavan et al. A computer-aided approach to detect the fetal behavioral states using multi-sensor Magnetocardiographic recordings
Cheng et al. A comparison between computerised (mean range) and clinical visual cardiotocographic assessment
Govindan et al. Early maturation of sinus rhythm dynamics in high-risk fetuses
Mandruzzato et al. Computerised evaluation of fetal heart rate in post‐term fetuses: long term variation
Spencer Predictive value of a fetal heart rate acceleration at the time of fetal blood sampling in labour
de Vries et al. Contrastive predictive coding for anomaly detection of fetal health from the cardiotocogram
Gu et al. A study of maternal hemodynamic change during healthy pregnancy and women with gestation hypertension

Legal Events

Date Code Title Description
FZDE Discontinued